Aug 22, 2018
Abreos Biosciences Launches Laboratory Developed Test for Precision Dose Monitoring of Natalizumab (Tysabri)
Aug 21, 2018
ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Aug 17, 2018
Ology Bioservices Wins $8.4 Million Defense Department Award to Produce Anti-Ebola Medical Countermeasure
Aug 15, 2018
Agenus Receives Second Milestone Payment from Merck
Aug 14, 2018
ProMIS Neurosciences Announces Second Quarter 2018 Results
Aug 07, 2018
I-Mab Biopharma and MorphoSys Announce China IND Submission of TJ202/MOR202
Aug 07, 2018
ProMIS Neurosciences Issues Narrated Commentary on Key Learnings from AAIC 2018
Aug 03, 2018
CAR T Cell Therapy Market Global Trends, Growth Drivers, Targeted Antigens Opportunities and Forecast to 2028
Jul 31, 2018
ProMIS Neurosciences Issues White Paper Entitled 'State of the Art at AAIC 2018'
Jul 26, 2018
I-Mab Biopharma and ABL Bio Announce Global Collaboration on Innovative Bispecific Antibodies
Jul 16, 2018
Agenus Appoints Regulatory and Clinical Heads
Jul 10, 2018
Applied BioMath, LLC Announces Collaboration with Revitope for Mechanistic PK/PD Modeling in Solid Tumors
Jul 10, 2018
ProMIS Neurosciences to Present Preclinical Data on Alzheimer's Disease Therapeutic Antibody PMN310 at Alzheimer's Association International Conference
Jul 09, 2018
MabVax Therapeutics and Boehringer Ingelheim Sign Asset Purchase and License Agreement and Related Agreements for an Antibody Development Program Targeting Multiple Solid Tumor Cancers
Jul 09, 2018
US FDA Approves Adagene IO program IND for Solid Tumor and Non-Hodgkin Lympoma Ph1 trial
Jul 02, 2018
Compugen Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology Therapeutic Antibody
Jun 13, 2018
CStone Pharmaceuticals Initiates Two Pivotal Phase II Studies of the Anti-PD-L1 Monoclonal Antibody CS1001
Jun 12, 2018
Agenus Discovery Enhances Activity of Cancer Fighting Antibodies; Findings Published in Cancer Cell
Jun 12, 2018
ProMIS Neurosciences Initiates Manufacturing of PMN310, its Lead Therapeutic Antibody for Treatment of Alzheimer's Disease
Jun 04, 2018
Agenus Presents Clinical Responses of AGEN1884 (anti-CTLA-4) and AGEN2034 (anti-PD-1) at ASCO 2018